Immunological
Cluster outbreaks described as early as 1934 at Los Angeles County General Hospital; formal clinical descriptions consolidated through the 1950s.
Myalgic encephalomyelitis occupies a contested and complex position in medical history, having been recognized under various names across the twentieth century before generating sustained scientific and institutional debate about its nature and legitimacy. Clusters of illness bearing its hallmark features were documented at hospitals and communities around the world from the 1930s onward, prompting fierce disagreement among physicians about whether the condition was organic, psychiatric, or something else entirely. Its history is inseparable from the broader story of how medicine has grappled with illnesses that resisted the diagnostic technologies and conceptual frameworks of their era.
Historical Narrative
The illness that eventually came to be called myalgic encephalomyelitis first attracted sustained medical attention through a series of cluster outbreaks that struck institutions and communities in the mid-twentieth century. In 1934, an unusual outbreak of a debilitating condition affected staff at Los Angeles County General Hospital, with symptoms that did not conform neatly to any recognized disease. Epidemiologist Alexander Gilliam conducted a rigorous investigation of this outbreak, publishing a detailed report that documented the illness's unusual character and its predilection for medical personnel. His work represented one of the first sustained attempts to characterize what later researchers would recognize as a pattern recurring across geography and time.
Over the following decades, similar outbreaks were reported in Iceland, in the Royal Free Hospital in London, in Punta Gorda, Florida, and in numerous other locations across North America, Europe, and beyond. Each outbreak generated local medical attention, and researchers including Alexis Shelokov and Donald Henderson contributed careful epidemiological analyses of individual clusters. The accumulation of these reports eventually drew the attention of the British physician Melvin Ramsay, who became the condition's most dedicated early advocate. Ramsay, working at the Royal Free Hospital in London, observed patients from the 1955 outbreak there and followed many of them over subsequent years. He argued systematically that the condition was a genuine organic illness with a characteristic profile, and he worked to establish clinical criteria and to document the illness's tendency toward prolonged and fluctuating courses.
Ramsay was instrumental in establishing the term 'myalgic encephalomyelitis,' which had appeared in a 1956 editorial in The Lancet to describe the Royal Free outbreak. He preferred this terminology because it gestured toward the muscle pain and nervous system involvement he believed central to the illness, and he spent much of his career insisting on the condition's organic reality at a time when institutional medicine was moving toward skepticism.
That skepticism reached its most influential expression in the 1970s when two British psychiatrists, Colin McEvedy and A.W. Beard, reanalyzed the Royal Free outbreak and proposed that it represented a case of mass hysteria rather than organic disease. Their reinterpretation proved highly influential within British and international medicine and contributed to decades of controversy that shaped research priorities, healthcare policy, and the experiences of patients profoundly. The mass hysteria hypothesis was contested vigorously by Ramsay and others, but it cast a long institutional shadow.
Through the 1980s the condition intersected with emerging debates around what was being called chronic fatigue syndrome in the United States, following a cluster investigation in Incline Village, Nevada, which drew substantial research attention. Canadian physician Byron Hyde undertook extensive clinical investigations and contributed to efforts to codify diagnostic criteria. The condition's precise relationship to parallel diagnostic categories debated simultaneously in North America and Europe remained unresolved through the end of the twentieth century, with competing research paradigms generating ongoing disagreement about etiology, classification, and the appropriate frameworks for investigation. The history of myalgic encephalomyelitis became itself a subject of scholarly analysis, examined as a case study in how biomedicine constructs, contests, and sometimes struggles to accommodate illness.
Key Historical Figures
Historical narrative only — this page describes how Myalgic encephalomyelitis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.